HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Revision of DEGUM ultrasound criteria for grading internal carotid artery stenoses and transfer to NASCET measurement].

Abstract
Since 1986, German ultrasound criteria for grading carotid stenosis have followed the local diameter reduction percentage consistent with the definition used in the European Carotid Surgery Trial (ECST) definition. To overcome the confusion caused by the coexisting grading method used in the North American Symptomatic Carotid Endarterectomy Trial (NASCET), a German interdisciplinary council on carotid artery stenosis has recommended the implementation of the NASCET grading system (distal diameter reduction percentage) as the standard. The multi-parametric German "DEGUM ultrasound criteria" consisting of combined Doppler and imaging criteria have consequently been revised and transferred to the NASCET definition. In addition, a novel differentiation between main (primary) and additional (secondary) criteria has been proposed. When these ultrasound criteria are combined, vascular sonography allows reliable grading of carotid disease.
AuthorsC Arning, B Widder, G M von Reutern, H Stiegler, M Görtler
JournalUltraschall in der Medizin (Stuttgart, Germany : 1980) (Ultraschall Med) Vol. 31 Issue 3 Pg. 251-7 (Jun 2010) ISSN: 1438-8782 [Electronic] Germany
Vernacular TitleUltraschallkriterien zur Graduierung von Stenosen der A. carotis interna - Revision der DEGUM-Kriterien und Transfer in NASCET-Stenosierungsgrade.
PMID20414854 (Publication Type: Journal Article, Review)
CopyrightCopyright Georg Thieme Verlag KG Stuttgart . New York.
Topics
  • Blood Flow Velocity (physiology)
  • Carotid Artery, Internal (diagnostic imaging)
  • Carotid Stenosis (classification, diagnostic imaging)
  • Germany
  • Humans
  • Practice Guidelines as Topic
  • Sensitivity and Specificity
  • Ultrasonography, Doppler, Color

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: